Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Notes Payables: 2014-2016

Historic Notes Payables for BIO-TECHNE (TECH) over the last 3 years, with Jun 2016 value amounting to $3.8 million.

  • BIO-TECHNE's Notes Payables rose 282.83% to $14.6 million in Q1 2017 from the same period last year, while for Mar 2017 it was $14.6 million, marking a year-over-year increase of 282.83%. This contributed to the annual value of $3.8 million for FY2016, which is 6.59% down from last year.
  • As of FY2016, BIO-TECHNE's Notes Payables stood at $3.8 million, which was down 6.59% from $4.0 million recorded in FY2015.
  • BIO-TECHNE's 5-year Notes Payables high stood at $5.9 million for FY2014, and its period low was $3.8 million during FY2016.
  • Its 3-year average for Notes Payables is $4.6 million, with a median of $4.0 million in 2015.
  • Data for BIO-TECHNE's Notes Payables shows a maximum YoY tumbled of 32.36% (in 2015) over the last 5 years.
  • Yearly analysis of 3 years shows BIO-TECHNE's Notes Payables stood at $5.9 million in 2014, then tumbled by 32.36% to $4.0 million in 2015, then fell by 6.59% to $3.8 million in 2016.